Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06074666 · ClinicalTrials.gov registry record · NA

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

A NA study of Acute Lymphoblastic Leukemia, Pediatric, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06074666 is a NA study of Acute Lymphoblastic Leukemia, Pediatric that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 100 participants, below the 111-participant average among 8 other Acute Lymphoblastic Leukemia, Pediatric trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06074666, a NA study of Acute Lymphoblastic Leukemia, Pediatric, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

Interventions

  • BEHAVIORAL CareMeds Intervention
  • BEHAVIORAL Usual Care Group

Study Locations (1)

New York

  • Roswell Park Comprehensive Cancer Center - Buffalo

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-11-07
Est. Completion 2027-10-01
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT06074666

The ClinicalTrials.gov registry entry for NCT06074666 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 8 other Acute Lymphoblastic Leukemia, Pediatric trials with a reported enrollment target (10% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Lymphoblastic Leukemia, Pediatric appearing as the primary indexed condition, and to 2 interventions - of which CareMeds Intervention is the first listed.

NCT06074666 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06074666 about?

NCT06074666 is a clinical study titled "Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3". The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

What is the current status of trial NCT06074666?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-11-07. Estimated completion is 2027-10-01.

What conditions does trial NCT06074666 study?

This clinical trial studies the following conditions: Acute Lymphoblastic Leukemia, Pediatric.

What interventions are being tested in trial NCT06074666?

The interventions under investigation include: CareMeds Intervention (BEHAVIORAL), Usual Care Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT06074666?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06074666 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Lymphoblastic Leukemia, Pediatric

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.